PAHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Phibro Animal Health Corp (PAHC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company's strong financial performance, bullish technical indicators, and raised guidance outweigh the insider selling. The stock is well-positioned for long-term growth.
The technical indicators are bullish. The MACD histogram is positive and expanding, RSI is neutral at 76.821, and moving averages show a bullish trend (SMA_5 > SMA_20 > SMA_200). The stock is trading above the pivot level of 52.654, with resistance at 55.042 and 56.517, and support at 50.267 and 48.792.
Strong Q2 financial performance with 20.90% YoY revenue growth, 762.14% YoY net income growth, and 737.50% YoY EPS growth.
Raised FY26 guidance and margin expansion.
Bullish technical indicators and upward price momentum.
Insider selling has increased significantly, with the CEO selling 72,198 shares recently.
Neutral hedge fund activity and no significant trading trends.
Options data shows a bearish sentiment in open interest.
In Q2 2026, the company reported revenue of $373.91M (+20.90% YoY), net income of $27.46M (+762.14% YoY), EPS of $0.67 (+737.50% YoY), and gross margin of 35.7% (+6.66% YoY). These metrics highlight strong financial growth and operational efficiency.
Morgan Stanley raised the price target from $45 to $49 and maintained an Equal Weight rating. The analyst notes solid execution in the Animal Health segment, cost management, and the Zoetis MFA transaction, along with a Q2 beat and raised FY26 guidance.
